AzTrials
AzTrials

AnxietyAnx-RSNCT07305688

Climate Anxiety in a Young Population at Risk of Suicide

An observational study of Anxiety and Suicidal Ideation, run by Centre Hospitalier Esquirol at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Climate change has become a major source of concern, particularly among younger generations who are facing the progressive degradation of ecosystems, loss of biodiversity, and alarming environmental information disseminated through the media. Read more about this study

Who is it for?
Ages 16 to 24 years
Conditions the study is for
Anxiety, Suicidal Ideation, Mental Health Issue
What is being tested?
Columbia Suicide Severity Rating Scale, Climate Change Anxiety Scale - French version and State-Trait Anxiety Inventory, French version
How many people
108 participants
Where
1 siteFrance
Study dates
15 Dec 2025to 15 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 24 years
  • All sexes
  • Child, Adult

Study population: The study population consists of 108 adolescents and young adults aged 16 to 24 years, recruited within the Esquirol Hospital Center (France). Participants are approached in adult and pediatric emergency departments, adult psychiatry, and child and adolescent psychiatry units, as well as during outpatient consultations.

Who may be able to join

  • Men and women, boys and girls ;
  • Aged between 16 and 24;
  • Participants seen in adult or pediatric emergency departments, hospitalised in adult psychiatry or in child and adolescent psychiatry, or seen in outpatient consultation at Esquirol Hospital Center ;
  • Affiliated with a social security scheme or entitled to coverage under one ;
  • Having received full information about the study and having co-signed, together with the investigator, an informed consent form to participate in the study.
  • For minor participants: the consent to participate in the study must be signed by the holder(s) of parental authority, and the minor's assent will also be required.

Who cannot join

  • Participants will not be included in the study if their health condition is incompatible with understanding or completing the questionnaires used. This includes, in particular ;
  • Any chronic somatic pathology or major sensory impairment (for example : deafness or blindness) preventing reading, comprehension or communication with healthcare professionals ;
  • Any severe psychiatric pathology that significantly impairs cognitive or communication abilities, such as acute psychotic disorders, pervasive developmental disorders or confusional states ;
  • Participants hospitalised in units specialising in severe psychiatric disorders with major impairment of cognitive functions.
  • Adults under legal protection, in accordance with article L 1121-8 of the Public Health Code ;
  • Insufficient command of the French language

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Florence BOSSELUT, PhD contact

florence.bosselut@ch-esquirol-limoges.fr

France1 site, 1 recruiting
  • Hospital Esquirol Center

    Limoges, 87025

    Bertrand OLLIAC, Professor, bertrand.olliac@unlim.fr

    Mireille BELLE MBOU, PhD, mireille.bellembou@ch-esquirol-limoges.fr

    Recruiting

Other trials in France

About this study

Climate change has become a major source of concern, particularly among younger generations who are facing the progressive degradation of ecosystems, loss of biodiversity, and alarming environmental information disseminated through the media. The direct perception of climate-related disruptions has been shown to engender a profound sense of helplessness and loss. This distress, termed eco-anxiety, is characterised by feelings of fear, sadness and guilt regarding the planet's future.

In a context where there has been a marked increase in suicidal thoughts and attempts among young people over the past decade, it is essential to explore the psychological manifestations of eco-anxiety within this vulnerable population. The paucity of studies investigating this association underscores the significance of the present research.

Read more

The aims of this study is to examine the relationship between climate anxiety and suicidal risk among young people aged 16 to 24 years.

The study will encompass 108 young participants aged between 16 and 24 years, who are either hospitalised or receiving outpatient psychiatric care.

Each participant will be required to complete one clinician-administered assessment, namely the Columbia Suicide Severity Rating Scale (C-SSRS), and two self-report questionnaires: the Climate Change Anxiety Scale - French version (CCAS-FR) and the State-Trait Anxiety Inventory (STAI-Y).

Furthermore, a sociodemographic questionnaire will be administered in order to collect information regarding the subjects' age, sex, education level, living conditions, and psychiatric history.

It is hypothesised that there is a positive association between climate anxiety and suicidal risk, with the most eco-anxious participants showing higher C-SSRS scores. It is further predicted that eco-anxiety will correlate with elevated levels of state and trait anxiety, with the potential for modulating this relationship by sociodemographic factors, including gender.

This study will contribute to a better understanding of the psychological impacts of climate change on young people and help identify the most vulnerable profiles.

Read the detailed description

The Anx-RS France study investigates the association between climate change-related anxiety (eco-anxiety) and suicidal ideation among young people aged 16 to 24 years in France. Growing evidence suggests that climate change may contribute to psychological distress and feelings of hopelessness in younger generations. However, data on the link between eco-anxiety and suicide risk in this age group remain limited.

This is an observational, cross-sectional study including 108 participants recruited from university settings and the general population in France. Eligible participants are aged 16-24 years, fluent in French, and provide informed consent (parental consent is obtained for minors). Participants will be excluded if they have a health condition that prevents them from understanding or completing the study questionnaires. This includes major sensory impairments (e.g., deafness, blindness), severe psychiatric disorders affecting cognition or communication (e.g., acute psychosis, pervasive developmental disorder, confusional state), or current hospitalization in specialized psychiatric units for severe mental illness.

Participants complete a self-administered online survey composed of three validated instruments:

  • Climate Change Anxiety Scale (CCAS) - measuring anxiety, rumination, and functional impairment related to climate change.
  • State-Trait Anxiety Inventory (STAI-T/Y) - assessing general trait anxiety levels.
  • Columbia Suicide Severity Rating Scale (C-SSRS) - evaluating suicidal ideation and behavior.

Descriptive analyses will estimate the prevalence and intensity of climate-related anxiety. Correlational and multivariate analyses will assess the association between eco-anxiety (CCAS) and suicidal ideation (C-SSRS), adjusting for general anxiety levels (STAI-T/Y).

The results will improve understanding of how climate-related distress affects mental health and suicide risk among young people in France, and support prevention strategies and mental-health policy adaptation to emerging environmental stressors.

Being tested
Columbia Suicide Severity Rating Scale, Climate Change Anxiety Scale - French version, State-Trait Anxiety Inventory, French version, Socio demographic profil
Keywords
Eco-anxiety, Anxiety disorders, Suicide risk, Mental health, Young adults
Medical subject headings
Anxiety Disorders, Suicidal Ideation, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Columbia Suicide Severity Rating ScaleOther

    Standardized tool for evaluating suicidal ideation and behavior. Measures severity and intensity of suicidal thoughts and actions.

  • Climate Change Anxiety Scale - French versionOther

    22-item self-report questionnaire assessing cognitive, emotional, functional, and pro-environmental dimensions of climate change-related anxiety.

  • State-Trait Anxiety Inventory, French versionOther

    40-item self-report inventory measuring both state and trait anxiety levels.

  • Socio demographic profilOther

    Collects demographic and background variables such as age, gender, education level and living conditions.

Study groups in NCT07305688
Study groupRoleWhat they receive
Young Population at Suicide RiskAdolescents and young adults aged 16-24 years, recruited from emergency, inpatient, and outpatient psychiatry units at Esquirol Hospital Center (France). Participants complete standardized questionnaires assessing climate change anxiety (CCAS-FR), suicidal ideation and behavior (C-SSRS), and general anxiety (STAI-C or STAI-Y).
Receives: Other: Columbia Suicide Severity Rating Scale; Other: Climate Change Anxiety Scale - French version; Other: State-Trait Anxiety Inventory, French version; Other: Socio demographic profil

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Climate Change Anxiety Score

    Global score from the 13-item French version of the Climate Change Anxiety Scale (CCAS-FR), obtained by summing the cognitive, emotional, and functional disturbance subscales. Higher scores indicate greater levels of climate change-related anxiety.

    Score ranges 13 to 65

    Measured: 10 min

  2. Suicide Risk Score

    Overall score of suicidal ideation and behavior assessed using the Columbia Suicide Severity Rating Scale (C-SSRS). Higher scores indicate greater suicide risk Score ranges from 2 to 25.

    Measured: 10 min

Secondary outcomes (2)
  1. Extended Dimensions of Climate Change Anxiety

    Subdimension scores from the extended version of the CCAS-FR, assessing cognitive, emotional, and functional disturbances, as well as direct or indirect experience of climate change and pro-environmental behaviors.

    Measured: 10 min

  2. State and Trait Anxiety Scores

    Anxiety levels measured using the State-Trait Anxiety Inventory (STAI). The STAI-C is used for participants aged 16-17 years, and the STAI-Y for those aged 18-24 years. Separate state and trait anxiety scores will be analyzed Score ranges 20 to 80

    Measured: 20 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2025
  2. Study start15 Dec 2025
  3. Primary completion15 Mar 2027 (estimated)
  4. Study completion15 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07305688
Sponsor's protocol ID
2025-A00139-40
Acronym
Anx-RS
Status last verified
Jun 2026
First submitted
12 Dec 2025
Last updated
4 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anxiety and Suicidal Ideation, run by Centre Hospitalier Esquirol at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mireille BELLE MBOU, PhD (0587509130, mireille.bellembou@ch-esquirol-limoges.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Climate Change Anxiety Score (time frame: 10 min). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in